• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA - PRINCETON DURASEAL EXACT SPINE SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL SPINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA - PRINCETON DURASEAL EXACT SPINE SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL SPINE Back to Search Results
Catalog Number 206520
Medical Device Problem Code Improper Chemical Reaction (2952)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/22/2025
Type of Reportable Event Malfunction
Event or Problem Description
A facility reported that while in contact with a patient, duraseal exact spine sealant system (206520) could not turn into hydrogel formation.There was no patient injury and no delay in surgery noted.
 
Additional Manufacturer Narrative
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
 
Additional Manufacturer Narrative
Updated fields: d4, d9, g3, g6, h2, h3, h4, h11.The duraseal exact spine sealant system (206520) was returned for evaluation: device history record (dhr) review - the dhr was reviewed, and no anomalies were found during the manufacturing and packaging process that could be related to the reported condition.Failure analysis - the sample received back included 1 assembly (borate/phosphate syringes, y-connector and both holders), y-connector, 4 loose spray tips, and 1 vial.The loose spray tips and y-connector were visually inspected, only one spray tip looked unused while the others presented signs of usage.No damages were detected in any of the spray tips.The assembly received was inspected and no damages were detected.Both syringes were empty as a sign that they were totally used, and residue of dry solution was observed.The vial was also received empty, but residue of peg mixed with phosphate could be observed.The solution was still in a liquid state and no discrepancies were detected on the mixed product.With the sample available for evaluation, the failure mode reported could not be confirmed.It could not be tested nor confirmed if the solution after mixing could not be formed.Root cause - the root cause is undetermined, and the complaint was unable to be confirmed.Product received was tested and the failure mode reported was not confirmed.Per the dfmea, potential causes of failure include issues with solution, mixing and coverage.The risk remains acceptable per the risk analysis.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASEAL EXACT SPINE SEALANT SYSTEM 5ML US BOX OF 5
Common Device Name
DURASEAL SPINE
Manufacturer (Section D)
INTEGRA - PRINCETON
1100 campus road
1100 campus road
princeton NJ 08540
Manufacturer (Section G)
INTEGRA - PRINCETON
1100 campus road
none
princeton NJ 08540
Manufacturer Contact
vivian nelson
1100 campus drive
princeton, NJ 08540
6099362319
MDR Report Key21380292
Report Number3003418325-2025-00007
Device Sequence Number15568772
Product Code NQR
UDI-Device Identifier10381780000044
UDI-Public10381780000044
Combination Product (Y/N)N
PMA/510(K) Number
P080013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,User Facility,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number206520
Device Lot Number60521863
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/23/2025
Supplement Date Received by Manufacturer02/18/2025
Initial Report FDA Received Date02/13/2025
Supplement Report FDA Received Date03/07/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-